Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy a health technology assessment
The purpose of this health technology assessment (HTA) is to conduct a systematic assessment of the clinical effectiveness, safety, cost-effectiveness, and perspectives and experiences of pregnant persons, partners, and health care providers regarding the screening of pregnant persons for Chlamydia...
Main Author: | |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
2018, November 2018
|
Series: | CADTH health technology assessment report
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this health technology assessment (HTA) is to conduct a systematic assessment of the clinical effectiveness, safety, cost-effectiveness, and perspectives and experiences of pregnant persons, partners, and health care providers regarding the screening of pregnant persons for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) during pregnancy |
---|---|
Item Description: | "PROSPERO Registration Number: CRD42018087016" |
Physical Description: | 1 PDF file (181 pages) illustrations |